All

× UPDATE! Updated as of 05 April 2024.
Records 141 to 160 of 32210
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1276 Human Albumin Alburx 250 g/L (25 % w/v) Solution for Intravenous Infusion Prescription Drug (Rx) Plasma fractions for specific uses CSL Behring AG Switzerland Automatic Renewal 05 January 2023 07 June 2028
View BR-1277 Human Albumin Alburx 200 g/L (20% w/v) Solution for Intravenous Infusion Prescription Drug (Rx) Plasma fractions for specific uses CSL Behring LLC U.S.A. BR-1277 03 January 2023 07 June 2028
View BR-1278 Human Albumin Alburx 250 g/L (25% w/v) Solution for Intravenous Infusion Prescription Drug (Rx) Plasma fractions for specific uses CSL Behring LLC U.S.A. BR-1278 31 December 2022 07 June 2028
View BR-1279 Etanercept Etveza 25 25mg Lyophilized Powder for Subcutaneous Injection Prescription Drug (Rx) Immunosuppressant/ Tumor Necrosis Factor Alpha Inhibitor Shangpai CP Guojian Pharmaceutical Co., Ltd China Initial (Compliance) 19 November 2019 11 July 2024
View BR-1280 Atezolizumab Tecentriq 60 mg/mL (1.2 g/20 mL) Concentrate for Solution for Infusion Prescription Drug (RX) - Roche Diagnostics GmbH Germany Monitored Release (Variation) 22 February 2023 22 February 2028
View BR-1282 Eptacog alfa activated NovoSeven RT 1 mg/vial (50KIU/vial) Powder And Solvent For Solution For Injection Prescription Drug (RX) Blood Coagulation Factor Novo Nordisk A/S Denmark Renewal 01 August 2023 25 July 2028
View BR-1284 Isophane Insulin (Recombinant DNA) Humulin N 100 Units/mL Suspension for Injection (SC) Prescription Drug (RX) - Lilly France S.A.S. France Renewal 11 October 2022 31 October 2027
View BR-1287_PI_01.pdf BR-1287 Ustekinumab Stelara 45mg/ 0.5mL Solution for Injection Prescription Drug (Rx) - Cilag AG Switzerland - 10 May 2019 10 May 2024
View BR-1289 Rotavirus Vaccine (Live, Attenuated) Rotasiil Formulation: After reconstitution, each dose (2.5 mL) contains: Live Attenuated Bovine-Human Rotavirus Reassortant [G1, G2, G3, G4 and G9]* >10^5.6 FFU/Serotype *Grown on vero cells Freeze-dried Powder for Oral Suspension Prescription Drug (RX) - Serum Institute of India Private Limited India - 18 March 2022 08 February 2027
View BR-1290 Inactivated Poliomyelitis Vaccine (Types 1, 2 And 3) Poliovac 0.5 mL Suspension For Injection (IM/SC) Prescription Drug (RX) - Serum Institute of India Private Limited India Initial (Variation) 09 February 2023 09 February 2028
View BR-1291_PI_01.pdf BR-1291 Liraglutide SAXENDA 6mg/ mL Solution for Injection Prescription Drug (Rx) Anti-Obesity NOVO NORDISK A/S Denmark Monitored Release 25 April 2019 25 April 2025
View BR-1292 Rabies Vaccine Inactivated (Freeze Dried) Rabivax-S each dose contains nlt 2.5 IU Solution For Intradermal Injection Prescription Drug (RX) - Serum Institute of India India - 06 May 2019 06 May 2024
View BR-1293 Rituximab Rituxikal (50) 500 mg/ 50 mL Concentrate for Solution for Infusion Prescription Drug (RX) - Sinergium Biotech S.A. Argentina - 24 May 2019 24 May 2024
View BR-1294 Rituximab Rituxikal 100 mg/ 10 mL Concentrate for Solution for Infusion Prescription Drug (RX) - Sinergium Biotech S.A. Argentina - 24 May 2019 24 May 2024
View BR-1296 Dulaglutide Trulicity 0.75 mg/0.5 mL Solution For Injection Prescription Drug (RX) Antidiabetic Eli Lilly and Company United States of America Monitored Release 08 October 2019 18 June 2025
View BR-1297_PI_01.pdf BR-1297 Dulaglutide Trulicity 1.5 mg/0.5 mL Solution For Injection Prescription Drug (Rx) Antidiabetic Eli Lilly and Company United States of America Monitored Release 08 October 2019 18 June 2025
View BR-1298_PI_01.pdf BR-1298 Ramucirumab Cyramza 10 mg/mL Concentrate For Solution For Infusion (IV) Prescription Drug (RX) - Eli Lilly & Company United States of America Monitored Release 17 March 2022 02 July 2024
View BR-1299_PI_01.pdf BR-1299 Ixekizumab Taltz 80mg/mL Solution For Injection (SC) Prescription Drug (RX) - Eli Lilly & Company United States of America Monitored Release 17 March 2022 08 July 2024
View BR-1300_PI_01.pdf BR-1300 Ixekizumab Taltz 80mg/mL Solution For Injection (SC) Prescription Drug (RX) - Eli Lilly & Company United States of America Monitored Release 17 March 2022 08 July 2024
View BR-1301_PI_01.pdf BR-1301 Daratumumab Darzalex 20 mg/mL Concentrate For Solution For Infusion (Iv) Prescription Drug (Rx) - Vetter Pharma-Fertigung GmbH & Co. KG Germany - 01 August 2019 01 August 2024